Medtech companies team up for new robot capable of treating stroke, aneurysm
Siemens Healthineers and Styker are collaborating on a new neurovascular robotic system capable of treating strokes, aneurysms and other high-risk ailments. The goal is to provide quick, effective care by including every aspect of patient care—the robotics, the imaging, the therapies—in the same ecosystem.
While Siemens Healthineers brings its imaging and robotics expertise to the partnership, Stryker has years of experience in the neurovascular space. The two medtech companies plan on working together to develop this new system and integrate it into modern workflows. Physician feedback will play a critical role throughout the development process to ensure the advanced robot is simple and straightforward to use.
“Neurovascular diseases—primarily strokes and aneurysms—carry a massive global burden,” Carsten Bertram, head of advanced therapies at Siemens Healthineers, said in a statement. “Stroke is the second-leading cause of death and the third-leading cause of disability in adults globally. We are excited to announce this partnership, especially with Stryker, a leading player in the field of neurovascular care. Together, we are uniquely positioned to create an ecosystem of image-guidance, robotics and devices. This meaningful innovation will enable physicians to deliver more precise and timely care to patients around the world.”
“Stryker and Siemens Healthineers have the joint goal to advance neurovascular care through innovation,” added Jim Marucci, president of Stryker’s neurovascular division. “By combining our deep expertise in stroke therapy devices with the leadership of Siemens Healthineers in robotics and imaging, we aim to simplify workflows, enhance precision, and accelerate care. Together, we are taking an important step toward transforming how neurovascular procedures are performed—and ultimately, working to improve outcomes for patients worldwide.”
